HF Advisory Group’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.28M | Buy |
1,637
+192
| +13% | +$150K | 0.5% | 74 |
|
|
2025
Q1 | $1.19M | Buy |
1,445
+224
| +18% | +$185K | 0.52% | 78 |
|
|
2024
Q4 | $943K | Sell |
1,221
-1,088
| -47% | -$840K | 0.43% | 85 |
|
|
2024
Q3 | $2.05M | Sell |
2,309
-48
| -2% | -$42.5K | 0.95% | 34 |
|
|
2024
Q2 | $2.13M | Sell |
2,357
-202
| -8% | -$183K | 1.1% | 22 |
|
|
2024
Q1 | $1.99M | Sell |
2,559
-41
| -2% | -$31.9K | 1.11% | 25 |
|
|
2023
Q4 | $1.52M | Sell |
2,600
-563
| -18% | -$328K | 0.97% | 36 |
|
|
2023
Q3 | $1.7M | Sell |
3,163
-466
| -13% | -$250K | 1.26% | 18 |
|
|
2023
Q2 | $1.7M | Buy |
3,629
+170
| +5% | +$79.7K | 1.34% | 17 |
|
|
2023
Q1 | $1.19M | Buy |
3,459
+605
| +21% | +$208K | 1.05% | 28 |
|
|
2022
Q4 | $1.04M | Buy |
+2,854
| New | +$1.04M | 1.06% | 25 |
|